GTR Home > Tests > Search results - Limb-girdle muscular dystrophy, type 1C

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1832567[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 29 tests for 1 condition in 13 labs

CLimb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (24)

CAutosomal Dominant Limb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (7)
Total targets (7)

CPan Cardiomyopathy Panel (51 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (89)
Total targets (51)

CCaveolinopathy Testing via the CAV3 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAutosomal Dominant Limb Girdle Muscular Dystrophy Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (387)
Total targets (434)

CCAV3. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CLimb-Girdle Muscular Dystrophy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (66)
Total targets (22)

CExpanded Neuromuscular Disorders: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (154)
Total targets (79)

CNeuromuscular Disorders: Gene Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (102)
Total targets (46)

CSudden Cardiac Arrest (SCA): Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (30)
Total targets (10)

CLong and Short QT Syndrome: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (32)
Total targets (12)

CCardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (229)
Total targets (104)

CHypertrophic Cardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (36)
Total targets (14)

CSudden Death Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Total conditions (187)
Total targets (67)

CNeuromuscular NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (126)
Total targets (50)

CCardiomyopathy panel

Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (134)
Total targets (61)

CCardiac conduction abnormalities panel

Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (79)
Total targets (33)

CLong QT syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (40)
Total targets (13)

Showing 1 to 20 of 29 tests for 1 condition in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk